Literature DB >> 7541579

The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome.

D B Kaufman1, B Kaplan, Y S Kanwar, M Abecassis, F P Stuart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7541579     DOI： 10.1097/00007890-199506270-00017

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  4 in total

Review 1.  Drug-induced thrombotic microangiopathy: incidence, prevention and management.

Authors:  R Pisoni; P Ruggenenti; G Remuzzi
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Tacrolimus (FK506)-Associated Renal Pathology.

Authors:  Parmjeet S Randhawa; Thomas E Starzl; Anthony Jake Demetris
Journal:  Adv Anat Pathol       Date:  1997-07       Impact factor: 3.875

Review 3.  Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.

Authors:  C M Spencer; K L Goa; J C Gillis
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

4.  Achalasia in a Patient Undergoing Hematologic Stem Cell Transplant After Exposure to Tacrolimus.

Authors:  Sencer Goklemez; Lauren M Curtis; Alao Hawwa; Alexander Ling; Daniele Avila; Theo Heller; Steven Z Pavletic
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2017-08-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.